Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,797,198)	$ (2,182,815)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation	425,844	121,226
Changes in operating assets and liabilities:
Prepaid assets	222,730	(28,390)
Accounts payable	796,208	(25,686)
Net cash used in operating activities	(2,352,416)	(2,115,665)
Cash flows from investing activities:
Net cash from investing activities
Cash flows from financing activities:
Net cash from financing activities
Effect of exchange rate changes on cash and cash equivalents	(11,510)
Net change in cash and cash equivalents	(2,363,926)	(2,115,665)
Cash and cash equivalents at beginning of period	28,094,936	10,261,671
Cash and cash equivalents at end of period	25,731,010	8,146,006
Supplemental disclosure of non-cash investing and financing activities:
Accrued offering costs		38,741
Accrued dividend		221,279
Issuance of common stock for accrued research and development expense	$ 1,132,013